Coronavirus vaccine developer CureVac raises $213 million in IPO: source - Reuters
6:16pm PDT - August 13th, 2020 stock-market - ReutersCureVac BV raised $213 million in its initial public offering on Thursday, a person familiar with the matter said, setting the stage for the first stock market debut of a company developing a promising vaccine to combat the novel coronavirus.